Hawaii Biotech Receives Tick-Borne Encephalitis Vaccine Grant
From the Hawaii Biotech archive: (Honolulu, August 11, 2009) -- Hawaii Biotech, Inc. was awarded a three-year $2.9 million SBIR phase II grant from the National Institute of Allergy and Infectious Disease to continue development of a vaccine to protect healthy in
Hawaii Biotech to Present West Nile Phase 1 Results at 2009 Barcelona Vaccine Conference
From the Hawaii Biotech archive: (Honolulu, June 24 2009) -- Hawaii Biotech, Inc., announced today that its chief scientist, Dr. Beth-Ann Coller, will be participating at the Phacilitate Vaccine Forum Barcelona 2009. As an invited speaker, Dr. Coller will present
Hawaii Biotech Reports Phase 1 Results for West Nile Virus Vaccine
From the Hawaii Biotech archive: (Honolulu, Feb. 25, 2009) -- Hawaii Biotech, Inc., today announced successful Phase 1 clinical trial results of its West Nile Virus vaccine in healthy volunteers. Hawaii Biotech is developing a West Nile recombinant sub-unit vacci
Hawaii Biotech Completes Dosing of Phase 1 Trial for West Nile Virus Vaccine
From the Hawaii Biotech archive: (HONOLULU, Dec. 15, 2008) -- Hawaii Biotech, Inc. announced today that it has completed dosing of healthy subjects in a multiple dose safety study of its West Nile Virus vaccine. President and CEO Elliot Parks, Ph.D., indicated th
Hawaii Biotech Among 'Five to Watch' by Thomson Reuters
From the Hawaii Biotech archive: (HONOLULU, Nov. 17, 2008) - Hawaii Biotech Inc.'s vaccine for West Nile virus was named one of five "most promising drugs entering Phase I trials" by Thomson Reuters, the world's leading source of intelligent information for busin
Hawaii Biotech Initiates Phase 1 Clinical Trial for West Nile Vaccine
From the Hawaii Biotech archive: (HONOLULU, June 23, 2008) -- Hawaii Biotech, Inc., President and CEO Elliot Parks, Ph.D., announced today that the company has initiated a Phase 1 clinical trial study with its West Nile vaccine candidate. The study, being conduct
Hawai'i Biotech Names Ian Frazer to Scientific Advisory Board
From the Hawaii Biotech archive: (HONOLULU, June 2, 2008) -- Hawai`i Biotech, Inc. Board of Directors and management are pleased to announce the appointment of Ian Frazer, M.D., to its Scientific Advisory Board (SAB). Professor Frazer is director of the Diamantin
Hawaii Biotech Receives Funding from the Pediatric Dengue Vaccine Initiative
From the Hawaii Biotech archive: HAWAII BIOTECH RECEIVES FUNDING FROM THE PEDIATRIC DENGUE VACCINE INITIATIVE
Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trial
From the Hawaii Biotech archive: HAWAII BIOTECH RECEIVES ALLOWANCE TO PERFORM WEST NILE VACCINE CLINICAL TRIALS
Hawaii Biotech CEO Len Firestone Steps Down; Carolyn Weeks-Levy Named Interim CEO
From the Hawaii Biotech archive: Contact: Robert F. Kay 808-732-0631 Email: rkay@lava.net
